ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0972

Hypoxia Promotes the Expression of ADAM9 by Tubular Epithelial Cells Which Enhances TGF-β1 Activation and Promotes Tissue Fibrosis in Lupus Nephritis

Masataka Umeda1, Abhigyan Satyam1, Nobuya Yoshida1, Rhea Bhargava1, Ryo Hisada1, Simin Jamaly1, Caroline Owen2 and George Tsokos3, 1Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 2Division of Pulmonary and Critical Care Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 3BIDMC, Boston, MA

Meeting: ACR Convergence 2021

Keywords: Renal, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 7, 2021

Title: Abstracts: SLE – Etiology & Pathogenesis (0970–0973)

Session Type: Abstract Session

Session Time: 2:30PM-2:45PM

Background/Purpose: Enhanced expression of transforming growth factor-beta (TGF-β) in the kidneys of patients with lupus nephritis (LN) can lead to progressive fibrosis, resulting in end-organ damage (J Immunol. 180, 1903-1912. 2008). We previously reported that a disintegrin and metalloproteinases 9 (ADAM9) enhances Th17 cell differentiation and autoimmunity by activating TGF-β1 (PNAS. 118, 2021). We hypothesized that ADAM9 in the kidney may accelerate fibrogenesis by activating TGF-β1.

Methods: We assessed the expression of ADAM9 in kidneys from MRL/lpr mice and control MPJ mice and determined the expression levels of ADAM9 in kidney cells. We conducted in vitro experiments using tubular epithelial cells (TEC) isolated from B6 mice and explored the mechanisms responsible for the upregulation of ADAM9 in tubular epithelial cells (TEC) and the subsequent activation of TGF-β1 by ADAM9 expressed in TEC. To assess the role of ADAM9 in the development of tubular-intestinal fibrosis in LN, we generated MRL/lpr.Adam9-/- mice and compared the intensity of renal fibrosis between Adam9 sufficient and deficient MRL/lpr mice.

Results: We identified ADAM9 to be highly expressed in tubules from MRL/lpr mice. The transcription factor hypoxia-inducible factor-1 alpha (HIF-1α) was found to promote the transcription of ADAM9 in TEC. TEC from Adam9-deficient mice exposed to the hypoxia inducer dimethyloxalylglycine (DMOG) failed to cleave the latency-associated peptide to produce bioactive TGF-β1 from latent TGF-β1. Co-culture of TEC from Adam9-deficient mice and fibroblasts with DMOG and latent TGF-β1 showed decreased production of type I collagen and alpha-smooth muscle actin (αSMA) by fibroblasts. Adam9-deficient MRL/lpr mice showed mitigated tubular-intestinal fibrosis.

Conclusion: Our findings have revealed that hypoxia promotes the expression of ADAM9 by TEC which is responsible for the development of interstitial fibrosis in LN by promoting the generation of fibroblast bioactive TGF-β1 [hypoxia (HIF-1α) -> ADAM9 -> TGF-β1 -> production of collagen I and αSMA by resident fibroblasts].


Disclosures: M. Umeda, None; A. Satyam, None; N. Yoshida, None; R. Bhargava, None; R. Hisada, None; S. Jamaly, None; C. Owen, AstraZeneca Biopharmaceuticals Inc, 3; G. Tsokos, None.

To cite this abstract in AMA style:

Umeda M, Satyam A, Yoshida N, Bhargava R, Hisada R, Jamaly S, Owen C, Tsokos G. Hypoxia Promotes the Expression of ADAM9 by Tubular Epithelial Cells Which Enhances TGF-β1 Activation and Promotes Tissue Fibrosis in Lupus Nephritis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/hypoxia-promotes-the-expression-of-adam9-by-tubular-epithelial-cells-which-enhances-tgf-%ce%b21-activation-and-promotes-tissue-fibrosis-in-lupus-nephritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hypoxia-promotes-the-expression-of-adam9-by-tubular-epithelial-cells-which-enhances-tgf-%ce%b21-activation-and-promotes-tissue-fibrosis-in-lupus-nephritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology